Find More Contacts for Ocunexus Therapeutics
Protected Content
Admin, Admin, Finance
Non-Management
1 email found
View contacts for Ocunexus Therapeutics to access new leads and connect with decision-makers.
View All Contacts
  • Company Type For Profit
  • Contact Email info@ocunexus.com
  • Phone Number (858) 677-0474

Ocunexus Therapeutics is a biopharmaceutical company that develops therapeutics for unmet clinical needs in ophthalmology. The company specializes in developing highly differentiated drug candidates based upon a novel mechanism of action called “Gap Junction Channel Modulation.” It has developed treatments for multiple front- and back-of-the-eye

diseases and disorders that would potentially alter the standard of care. In addition, the company's technologies are expected to be transferable to other acute and chronic disease indications.

Ocunexus is formerly known as CoDa Therapeutics, a pharmaceutical company focused on the development and commercialization of wound care therapeutics based on gap junction modulation. The company is based in San Diego, California.

Lists Featuring This Company

Closed Western US Health Care Companies
2,316 Number of Organizations • $30.6B Total Funding Amount • 3,165 Number of Investors
Closed Therapeutics Companies
642 Number of Organizations • $23.5B Total Funding Amount • 1,651 Number of Investors
Closed California Health Care Companies
1,553 Number of Organizations • $25.1B Total Funding Amount • 2,621 Number of Investors
Closed West Coast Biotechnology Companies
696 Number of Organizations • $29.9B Total Funding Amount • 2,122 Number of Investors

Frequently Asked Questions

Where is Ocunexus Therapeutics's headquarters? Ocunexus Therapeutics is located in San Diego, California, United States.Who invested in Ocunexus Therapeutics? Ocunexus Therapeutics has 5 investors including BioPacific Ventures and RMI Partners.How much funding has Ocunexus Therapeutics raised to date? Ocunexus Therapeutics has raised .When was the last funding round for Ocunexus Therapeutics? Ocunexus Therapeutics closed its last funding round on Jan 12, 2021 from a Venture - Series Unknown round.Who are Ocunexus Therapeutics's competitors? Alternatives and possible competitors to Ocunexus Therapeutics may include AVEO OncologyAimmune Therapeutics, and Lucy Therapeutics.